Inna Zhuranskaya attended the HSBC Innovation Banking Oncology Innovation Day, which brought together venture investors, pharmaceutical leaders, innovators, government representatives, and other industry thought leaders.
Notable speakers included:
- Steve Bates OBE FMedSci – The UK Government’s Life Sciences Officer, who presented his vision for the future of the sector.
- Chris Baker – Discussed the investment landscape, emphasising that genuine patient impact is the ultimate differentiator.
- Hoyin Lam, PhD – Participated in a panel discussion on partnerships and licensing with pharmaceutical companies.
Event Insights:
Attendees shared positive reflections on LinkedIn, highlighting the event’s value in fostering meaningful connections and discussions around both the challenges and the optimism within oncology innovation.
Key insights included:
- Pragmatic optimism – Despite ongoing challenges, there was a shared sense of optimism for the future of the UK and European oncology ecosystem.
- Focus on patient outcomes – A core message throughout the day was that true innovation must translate into tangible improvements for patients, rather than technological “bells and whistles”.
- Importance of unique data – The significance of capturing distinctive patient data to create a “flywheel for innovation” was strongly emphasised.